Glycosylation is a crucial post-translational modification that regulates cellular functions and the surrounding microenvironment. The abnormal expression of glycosyltransferases, essential enzymes in this process, has been linked to tumor development. In addition, long noncoding RNAs (lncRNAs) have been shown to exert a multifaceted regulatory influence on gene expression. Nevertheless, research on glycosyltransferase-related lncRNAs (GTRLs) in endometrial cancer (EC) is still unclear. In this study, we constructed a novel prognostic model based on GTRLs using univariate Cox regression, Lasso, and multivariate stepwise Cox regression analysis. Our findings identified four GTRLs that were significantly associated with the prognosis of EC patients. The Kaplan-Meier (KM) survival analysis revealed a notable reduction in overall survival (OS) among high-risk populations. Furthermore, independent prognostic assessments, receiver operating characteristic (ROC) curves and nomograms, demonstrated that risk scores derived from these GTRLs outperformed other clinical variables within the TCGA-UCEC clinical data set in predicting patient prognosis. And the low-risk cohort exhibited increased immune infiltration and decreased tumor purity. Additionally, significant differences in tumor mutation profiles were observed, with the tumor mutation burden (TMB) being higher in the low-risk cohort, suggesting a potentially better response to immunotherapy. Different patient subgroups also displayed varying sensitivities to several chemotherapeutic agents. Finally, the model's validity was confirmed through clinical specimens and in vitro experiments, which demonstrated that AC090617.5 and AP001107.9 can influence the proliferation, migratory functions, and cisplatin sensitivity of EC. Therefore, the prognostic features can effectively predict the prognosis of EC and guide therapeutic decision-making.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11886429 | PMC |
http://dx.doi.org/10.1021/acsomega.4c09071 | DOI Listing |
ACS Omega
March 2025
Department of Obstetrics and Gynecology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.
Glycosylation is a crucial post-translational modification that regulates cellular functions and the surrounding microenvironment. The abnormal expression of glycosyltransferases, essential enzymes in this process, has been linked to tumor development. In addition, long noncoding RNAs (lncRNAs) have been shown to exert a multifaceted regulatory influence on gene expression.
View Article and Find Full Text PDFFront Oncol
September 2022
Department of Hematology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Purpose: Colon adenocarcinoma (COAD) is the most common type of colorectal cancer (CRC) and is associated with poor prognosis. Emerging evidence has demonstrated that glycosylation by long noncoding RNAs (lncRNAs) was associated with COAD progression. To date, however, the prognostic values of glycosyltransferase (GT)-related lncRNAs in COAD are still largely unknown.
View Article and Find Full Text PDFFront Immunol
October 2022
Department of Plastic and Cosmetic Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Aberrant glycosylation, a post-translational modification of proteins, is regarded to engage in tumorigenesis and malignant progression of breast cancer (BC). The altered expression of glycosyltransferases causes abnormal glycan biosynthesis changes, which can serve as diagnostic hallmarks in BC. This study attempts to establish a predictive signature based on glycosyltransferase-related lncRNAs (GT-lncRNAs) in BC prognosis and response to immune checkpoint inhibitors (ICIs) treatment.
View Article and Find Full Text PDFFront Oncol
August 2022
Department of Thoracic Surgery, Jiangsu Province People's Hospital and the First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Background: Lung adenocarcinoma (LUAD) is one of the most fatal cancers in the world. Previous studies have shown the increase in glycosylation level, and abnormal expressions of related enzymes are closely related to various cancers. Long non-coding RNAs (lncRNAs) play an important role in the proliferation, metabolism, and migration of cancer cells, but the underlying role of glycosyltransferase (GT)-related lncRNAs in LUAD remains to be elucidated.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!